On the recordFebruary 3, 2016
I worry that this inappropriately treats biosimilars like generic drugs and will disincentivize manufacturers from entering the biosimilars marketplace.
Source
congress.govI worry that this inappropriately treats biosimilars like generic drugs and will disincentivize manufacturers from entering the biosimilars marketplace.
Pallone expresses concern over CMS's payment policy for biosimilars affecting market entry.
Share
More from Frank Pallone
New Jersey communities were buried under record snowfall. But apparently if you live in a state Trump doesn’t like, you’re on your own.
I knew it was not going to go well, but I didn't know it was going to be this bad.
Americans are deeply frustrated and concerned that the rapid and unceasing development of data centers is driving up their monthly energy bills.
Whether it's the hospitals, the doctors, the nurse, they're really trying to care for people.